Analysis of PRAME immunocytochemistry in 109 acral malignant melanoma in situ
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Clinical Pathology"
DOI: 10.1136/jcp-2022-208697
Abstract: Aims Preferentially expressed antigen in melanoma (PRAME) recently is a reliable immunohistochemistry (IHC) marker for distinguishing melanoma from other lesions. However, there are few articles focused on PRAME use in acral malignant melanoma, the most… read more here.
Keywords: prame; melanoma situ; melanoma; malignant melanoma ... See more keywords